Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 7, 1999, Pages 765-772

  Kawamoto, Yasuhiro ^a   Nakamura, Shinichi ^a   Akiguchi, Ichiro ^a   Kimura, Jun ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Brain derived neurotrophic factor; Human basal ganglia; Immnunohistochemistry; Multiple system atrophy; Parkinson disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; AGED; ARTICLE; ASTROCYTE; BIOACCUMULATION; BRAIN PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GLOBUS PALLIDUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHY DRAGER SYNDROME;

EID: 0032776113     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199907000-00010     Document Type: Article

References (56)

1. Leibrock J, Lottspeish F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989;341: 149-52
2. Barde Y-A, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549-53
3. Hyman C, Hofer M, Barde Y-A, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991;350:230-32
4. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J Neurochem 1992;59: 99-106
5. Skaper SD, Negro A, Facci L, Dal Toso R. Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2, 4, 5-trihydroxyphenylalanine-induced injury. J Neurosci Res 1993;34:478-87
6. Mizuno K, Carnahan J, Nawa H. Brain-derived neurotrophic factor promotes differentiation of striatal GABAegic neurons. Dev Biol 1994;165:243-56
7. Ventimiglia R, Mather PE, Jones BE, Lindsay RM. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 1995;7:213-22
8. Nakao N, Brundin P, Funa K, Lindvall O, Odin P. Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Dev Brain Res 1995;90: 92-101
9. Nakao N, Kokaia Z, Odin P, Lindvall O. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons. Exp Neurol 1995;131:1-10
10. Martínez-Serrano A, Björklund A. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 1996;16:4604-16
11. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiat 1988;51:745-52
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiat 1992;55:181-84
13. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-91
14. Adams RD, Van Bogaert L, Van Der Eecken H. Striato-nigral degeneration. J Neuropathol Exp Neurol 1964;23:584-608
15. Jellinger K, Danielczyk W. Striato-nigral degeneration. Acta Neuropathol (Berl) 1968;10:242-57
16. Fearnley JM, Lees AJ. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-42
17. Izumi K, Inoue N, Shirabe T, Miyazaki T, Kuroiwa Y. Failed levodopa therapy in striato-nigral degeneration. Lancet 1971;1:1355
18. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiat 1969;32:28-34
19. Spokes EGS, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure. Clinical, histological and neurochemical observations on four cases. J Neurol Sci 1979;4359-82
20. Oppenheimer DR, Esiri MM. Disease of the basal ganglia, cerebellum and motor neurons. In: Adams JH, Duchen LW, eds. Greenfield's neuropathology. 5th ed. London: Edward Arnold, 1992:988-1045
21. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100
22. Nakazato Y, Yamazaki H, Hirato J, Ishida Y, Yamaguchi H. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 1990;49:521-30
23. Costa C, Duyckaerts C, Cervera P, Hauw J-J. Oligodendroglial inclusions in multiple systemic atrophy. Rev Neurol 1992;148: 274-80
24. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-43
25. Chin SS-M, Goldman JE. Glial inclusions in CNS degenerative diseases. J Nueropathol Exp Neurol 1996;55:499-508
26. Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: A correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol (Berl) 1997;93:585-91
27. Kawamoto Y, Nakamura S, Nakano S, Oka N, Akiguchi I, Kimura J. Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain. Neuroscience 1996;74:1209-26
28. Kawamoto Y, Nakamura S, Akiguchi I, Kimura J. Immunohistochemical localization of brain-derived neurotrophic factor in the spinal cords of amyotrophic lateral sclerosis and non-amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol 1998;57: 822-30
29. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. α-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurisci Lett 1998;249:180-82
30. Gai WP, Power JHT, Blumbergs PC, Blessing WW. Multiple-system atrophy: A new α-synuclein disease? Lancet 1998;352:547-48
31. Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice? Nature Medicine 1998;4:755-57
32. Tu P-h, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998;44:415-22
33. Hohn A, Leibrock J, Bailey K, Barde Y-A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 1990;344:339-41
34. Hallböök F, Ibáñez CF, Persson H. Evolulionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991;6:845-58
35. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A. Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB. Neuron 1991;7:857-66
36. Götz R, Köster R, Winkler C, et al. Neurotrophin-6 is a new member of the nerve growth factor family. Nature 1994;372:266-69
37. Nilsson A-S, Fainzilber M, Falck P, Ibáñez CF. Neurotrophin-7: A novel member of the neurotrophin family from the zebrafish. FEBS Lett 1998;424:285-90
38. Goto S, Hirano A, Matsumoto S. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Neurology 1990;40:1051-56
39. 28K in the basal ganglia of patients with parkinsonism. Ann Neurol 1992;32:543-50
40. Ito H, Kusaka H, Matsumoto S, Imai T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 1996;47:1291-99
41. Eidelberg D, Takikawa S, Moeller JR, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 1993;33:518-27
42. Otsuka M, Ichiya Y, Kuwabara Y, et al. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: A positron emission tomographic study. J Neurol Sci 1996;144:77-83
43. Szabo J. Topical distribution of the striatal efferents in the monkey. Exp Neurol 1962;5:21-36
44. Szabo J. The efferent projections of the putamen in the monkey. Exp Neurol 1967;19:463-76
45. Johnson TN, Rosvold HE. Topographic projections on the globus pallidus and the substantia nigra of selectively placed lesions in the precommissural caudate nucleus and putamen in the monkey. Exp Neurol 1971;33:584-96
46. Langlais PJ, Godinez M, Powell HC, Garrett RS, Terry-Ferguson M, McRee RC. Early ultrastructural changes in blood vessels and mast cells in experimental Wernicke's encephalopathy. Alcohol Clin Exp Res 1999 (in press).
47. Dvorak AM, Mihm MC, Dvorak HF. Morphology of delayed type hypersensitivity reactions in man: II. Ultrastructural alterations affecting the microvascular and the tissue mast cells. Lab Invest 1976;34:179-91
48. Galli SJ. New concepts about the mast cell. New Engl J Med 1993;328:257-65
49. Okayama Y, Bradding P, Tunon-de-Lara JM, Holgate ST, Church MK. Cytokine production by human mast cells. In: G Marone, ed. Human basophils and mast cells: Biological aspects: Vol. 61. New York: Karger, 1993:114-34
50. Springer TA, Adhesion receptors of the immune system. Nature 1990;346:425-34
51. Calingasan NY, Park LCH, Uchida K, Gibson GE. Heme oxygenase-1 induction and 4-hydroxynonenal accumulation in vulnerable brain regions in an animal model of impaired oxidative metabolism. Soc Neurosci Abstr 1998;24:475
52. Calingasan NY, Park LCH, Calo LL, Trifiletti RR, Gandy SE, Gibson GE. Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol 1998;153:599-610
53. Romero IA, Rist RJ, Aleshaiker A, Abbott NJ. Metabolic and permeability changes caused by thiamine deficiency in immortalized rat brain microvessel endothelial cells. Brain Res 1997;756:133-40
54. Cohen RE, Talarico G, Noble G. Phenotypic characterization of mononuclear inflammatory cells in salivary glands of biobreeding rats. Arch Oral Bio 1997;42:649-55
55. Graeber MB, Streit WJ, Kreutzberg GW. Identity of ED2-positive perivascular cells in rat brain. J Neurosci Res 1989;22:103-6
56. Perry VH, Matyszak MK, Fearn, S. Altered antigen expression of microglia in the aged rodent CNS. Glia 1993;7:60-67